Update on Medullary Thyroid Cancer

被引：27
作者：
Hu, Mimi I. [1 ]
Ying, Anita K. [1 ]
Jimenez, Camilo [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2014年 / 43卷 / 02期
关键词：
Medullary thyroid carcinoma; MEN type 2; Pathophysiology; Diagnosis; Treatment; GROWTH-FACTOR RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; FINE-NEEDLE-ASPIRATION; RET PROTOONCOGENE MUTATIONS; DENDRITIC CELL VACCINATION; ANTIGEN DOUBLING-TIMES; PHASE-II TRIAL; PROGNOSTIC-FACTORS; TYROSINE KINASE; SOMATIC MUTATIONS;
D O I：
10.1016/j.ecl.2014.02.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, demonstrating variable behavior from indolent disease to highly aggressive, progressive disease. There are distinguishing phenotypic features of sporadic and hereditary MTC. Activation or overexpression of cell surface receptors and up-regulation of intracellular signaling pathways in hereditary and sporadic MTC are involved in the disease pathogenesis. There has been an exponential rise in clinical trials with investigational agents, leading to approval of 2 medications for progressive, advanced MTC. Developments in understanding the pathogenesis of MTC will hopefully lead to more effective and less toxic treatments of this rare but difficult to treat cancer.
引用
收藏
页码：423 / +
页数：21
相关论文
共 116 条
[61]   Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression - A multivariate analysis [J].
Machens, Andreas ;
Ukkat, Joerg ;
Hauptmann, Steffen ;
Dralle, Henning .
ARCHIVES OF SURGERY, 2007, 142 (03) :289-293
[62]   LONG-TERM TREATMENT OF METASTATIC MEDULLARY-THYROID CARCINOMA WITH THE SOMATOSTATIN ANALOG OCTREOTIDE [J].
MAHLER, C ;
VERHELST, J ;
DELONGUEVILLE, M ;
HARRIS, A .
CLINICAL ENDOCRINOLOGY, 1990, 33 (02) :261-269
[63]  
McHenry CR, 1999, SURGERY, V126, P677
[64]   Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis [J].
Meijer, Johannes A. A. ;
le Cessie, Saskia ;
van den Hout, Wilbert B. ;
Kievit, Job ;
Schoones, Johannes W. ;
Romijn, Johannes A. ;
Smit, Johannes W. A. .
CLINICAL ENDOCRINOLOGY, 2010, 72 (04) :534-542
[65]   Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: Mutational and functional analysis [J].
Mitsiades, Constantine S. ;
Kotoula, Vassiliki ;
Poulaki, Vassiliki ;
Sozopoulos, Elias ;
Negri, Joseph ;
Charalambous, Elpida ;
Fanourakis, Galinos ;
Voutsinas, Gerassimos ;
Tseleni-Balafouta, Sophia ;
Mitsiades, Nicholas .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3662-3666
[66]   RELATION OF DOUBLING TIME OF PLASMA CALCITONIN LEVELS TO PROGNOSIS AND RECURRENCE OF MEDULLARY-THYROID CARCINOMA [J].
MIYAUCHI, A ;
ONISHI, T ;
MORIMOTO, S ;
TAKAI, SI ;
MATSUZUKA, F ;
KUMA, K ;
MAEDA, M ;
KUMAHARA, Y .
ANNALS OF SURGERY, 1984, 199 (04) :461-466
[67]   Patterns of nodal metastases in palpable medullary thyroid carcinoma - Recommendations for extent of node dissection [J].
Moley, JF ;
DeBenedetti, MK .
ANNALS OF SURGERY, 1999, 229 (06) :880-887
[68]   Compartment-mediated dissection for papillary thyroid cancer [J].
Moley, JF ;
Wells, SA .
LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (01) :9-15
[69]   Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations [J].
Moley, JF ;
Lairmore, TC ;
Doherty, GM ;
Brunt, LM ;
DeBenedetti, MK .
SURGERY, 1999, 126 (04) :673-677
[70]   Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans [J].
Monsieurs, M ;
Brans, B ;
Bacher, K ;
Dierckx, R ;
Thierens, H .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (12) :1581-1587
234567891011